Update on neuromuscular pharmacology

Current Opinion in Anaesthesiology
Mohamed Naguib, Sorin J Brull

Abstract

We review the efficacy and safety of gantacurium and AV002, two novel, investigational fumarate-based nondepolarizing neuromuscular blockers, as well as sugammadex and cysteine, two novel reversal drugs that have no acetylcholinesterase inhibition properties. Gantacurium (with a pharmacodynamic profile similar to that of succinylcholine) and AV002 (with an intermediate duration of action) have shown efficacy in animals and, for gantacurium, in humans. Animal data have shown that exogenous administration of the amino acid cysteine accelerates the natural chemical degradation of both gantacurium and AV002 via the cysteine adduction pathway. Another reversal drug, sugammadex (a modified gamma-cyclodextrin and the first selective relaxant binding agent), forms very tight complexes in a 1: 1 ratio with steroidal neuromuscular blocking agents. In a multicenter phase-2 randomized controlled study in the European Union, the efficacy and safety of gantacurium were evaluated, but results have not yet been published. Sugammadex is currently available in the European Union, but the United States Food and Drug Administration has had concerns about its safety (hypersensitivity and allergic reactions) and has asked for additional safety data....Continue Reading

Associated Clinical Trials

References

Jan 1, 1976·Canadian Anaesthetists' Society Journal·R HughesN Sugai
Jun 1, 1979·Anesthesiology·Jørgen Viby-MogensenH Ording
Mar 1, 1975·Pharmacology, Biochemistry, and Behavior·L G ShapreB Gale
Jan 1, 1991·Advances in Experimental Medicine and Biology·M Friedman
Sep 1, 1991·The American Journal of Clinical Nutrition·L LaineJ Adams
Apr 1, 1991·British Journal of Anaesthesia·G H BeemerB A Robertson
Oct 13, 1972·Brain Research·J W OlneyB Schainker
Jan 1, 1983·British Journal of Anaesthesia·G B Drummond, N S Zhong
May 1, 1995·Journal of the Neurological Sciences·A R PeanD B Ramsden
Jul 1, 1996·Anesthesiology·William B WastilaJohn J Savarese
Nov 4, 2000·Neurochemical Research·R JanákyS S Oja
Nov 30, 2000·British Journal of Anaesthesia·Johannes H ProostJ M Wierda
Apr 9, 2002·Bioorganic & Medicinal Chemistry·Gary J TarverMing-Qiang Zhang
Sep 27, 2002·Organic Letters·K S CameronM-Q Zhang
Oct 16, 1952·The New England Journal of Medicine·F F FOLDESJ M BORREGO-HINOJOSA
Oct 1, 1951·Annals of the New York Academy of Sciences·D BOVET
Apr 17, 2004·Anesthesiology·Matthew R BelmontJohn J Savarese
Sep 30, 2005·Anesthesiology·Francois GijsenberghThijs van Iersel
Jan 24, 2006·Anesthesia and Analgesia·Guy CammuThierry Deloof
Feb 22, 2007·Anesthesia and Analgesia·Mohamed Naguib
Jul 19, 2008·Anesthesia and Analgesia·Sorin J BrullRonald D Miller
Jul 19, 2008·Anesthesia and Analgesia·Glenn S MurphyJeffery S Vender
Jan 1, 2009·Expert Review of Clinical Pharmacology·Mohamed Naguib, Sorin J Brull

Citations

Apr 18, 2013·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Junko TokuwakaMakoto Tanaka
Sep 10, 2010·Annals of Cardiac Anaesthesia·Thomas M HemmerlingDirk Nauheimer
Feb 16, 2011·Anaesthesia·L Menéndez-OzcoidiM J Salvador-Bravo
Jun 14, 2016·Journal of Clinical Anesthesia·Yuko YamadaHiroki Iida
Nov 9, 2011·Revista brasileira de anestesiologia·Ana Laura Colle KaulingGuilherme Muriano Brunharo
Feb 2, 2013·Korean journal of anesthesiology·Jin Young Chon
Apr 27, 2010·Anesthesia and Analgesia·Richard C PrielippSorin J Brull
Apr 2, 2015·Current Opinion in Anaesthesiology·Sarah DevroeSteffen Rex
Jan 30, 2014·Anaesthesia and Intensive Care·J JeyadossRraw Van Wijk
Mar 8, 2011·Anaesthesia and Intensive Care·P A BakerAustralian and New Zealand College of Anaesthetists
Jun 19, 2015·Current Opinion in Anaesthesiology·Paul M HeerdtJohn J Savarese

Related Concepts

GW 280430A
Org 25969
CW 002
Cholinesterase Inhibitors, Reversible
Neuromuscular Nondepolarizing Agents
Cysteine Hydrochloride
Isoquinolines
gamma-Cyclodextrins
Acetylcholinesterase
Cysteine

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie
Mohamed NaguibE A Bamgboye
Current Opinion in Pharmacology
Bethan Lang, Angela Vincent
Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie
D R Gambling
© 2021 Meta ULC. All rights reserved